IPO Stock Watch: Medical Device Maker Nevro Hits High
at Investor's Business Daily - Mon Dec 22, 4:45PM CST
JPMorgan raised its price target on Nevro (NVRO) to 42 from 34 and the stock rose 13% Monday, closing at an all-time high of 39.37. Nevro develops and markets an implantable spinal cord stimulation system called Senza, designed to treat chronic pain...
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), STJ: 66.67 (+0.67), NVRO: 37.95 (-0.93)
Boston Scientific To Participate In 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Mon Dec 22, 7:45AM CST
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 in San Francisco.
BSX: 13.13 (+0.07), JPM: 62.48 (unch)
Merit Medical Hits 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 2:20PM CST
Strong third-quarter results, a string of FDA approvals for its new products along with a robust product pipeline, all contribute to the growth trajectory of Merit Medical Systems, Inc. (MMSI).
BSX: 13.13 (+0.07), TFX: 116.82 (+0.28), ANGO: 19.19 (+0.33), MMSI: 17.17 (+0.01)
C. R. Bard, Cook Medical and Boston Scientific Lead the U.S. Nephrostomy Market
GlobeNewswire - Fri Dec 19, 1:51PM CST
via PRWEB - According to an in-depth U.S. urology report, from iData Research, the leading global authority in medical device market research, and the U.S. nephrostomy market is expected to approach over $110 million by 2020. This market includes percutaneous nephrostomy sets, nephrostomy balloon catheters, nephrostomy drainage tubes and ureteral stents. Market growth will be driven by the rise in percutaneous nephrostomy (PCN) procedures.
BSX: 13.13 (+0.07)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 340.89 (+5.13), VRX: 140.33 (-0.22), QLTI: 3.72 (+0.08), CTRX: 51.83 (+0.14), BCRX: 11.83 (+0.76), ACT: 254.20 (-1.68), MDT: 74.08 (+0.31), TKMR: 13.97 (+0.14), NEPT: 1.88 (+0.03), BSX: 13.13 (+0.07), AGN: 210.12 (+0.95), CMRX: 36.80 (+0.70), ALNY: 93.52 (+0.97), SRPT: 13.88 (+0.47), SHPG: 209.29 (+0.07), NLNK: 39.08 (+1.36), SNY: 46.35 (+0.50), MSLI: 1.67 (+0.02), NVCN: 6.60 (unch), CRME: 8.56 (+0.06), EBS: 27.64 (+1.28), GSK: 42.85 (+0.11), CELG: 109.60 (+3.48), GILD: 91.29 (+1.84), MRK: 57.46 (+0.25), NVDQ: 16.90 (+0.55), NVS: 93.91 (+0.66)
Philips Looks To Long-Time Laggard Volcano To Perk Up Its Healthcare Biz
Stephen Simpson, CFA - at Seeking Alpha - Fri Dec 19, 5:15AM CST
BSX: 13.13 (+0.07), PHG: 29.39 (-0.06), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67)
Spain Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, B. Braun Melsungen and Covidien
M2 - Fri Dec 19, 4:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/b5npzx/spain_surgical) has announced the addition of the "Spain Surgical Sutures Market Outlook to 2020" report to their offering. Our new report, "Spain Surgical Sutures Market Outlook to 2020", provides key market data on the Spain Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Automated Suturing Devices (Reusable and Disposable Automated Suturing Devices) and Sutures (Absorbable and .Non-Absorbable Sutures). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Sutures Market, Spain 4 Overview of Key Companies in Spain, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned: - Johnson & Johnson - B. Braun Melsungen AG - Covidien plc - Peters Surgical - Boston Scientific Corporation - Lorca Marin S.A. For more information visit http://www.researchandmarkets.com/research/b5...n_surgical
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31)
AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 2:37PM CST
Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
BSX: 13.13 (+0.07), BCR: 169.10 (-0.44), ANGO: 19.19 (+0.33), MMSI: 17.17 (+0.01)
Boston Scientific To Participate In Goldman Sachs CEOs Unscripted Healthcare Conference
PR Newswire - Thu Dec 18, 7:30AM CST
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs CEOs Unscripted Healthcare Conference on Tuesday, January 6, 2015 in Boston.
BSX: 13.13 (+0.07)
Pulmonx Names New Chief Executive Officer
Business Wire - Thu Dec 18, 7:01AM CST
Pulmonx Corporation, a leader in interventional pulmonology, today announced that Glen French has joined the company as President, Chief Executive Officer and member of the Board of Directors. Mr. French possesses deep experience leading and transforming pulmonology, respiratory and endoscopic businesses. Most recently, he was CEO of ApniCure, a developer of proprietary devices for the treatment of obstructive sleep apnea (OSA) and other sleep disorders.
BSX: 13.13 (+0.07)
CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 3:55PM CST
CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues with its sturdy performance in the international markets.
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), BCR: 169.10 (-0.44), ANGO: 19.19 (+0.33)
Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 13.13 (+0.07), SPNC: 34.50 (+0.59), ABT: 45.70 (-0.02), PHG: 29.39 (-0.06), MDT: 74.08 (+0.31), TRIV: 13.47 (-0.40), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02), ELGX: 15.35 (-0.06), ATRC: 18.76 (+0.13), NVDQ: 16.90 (+0.55)
Global Markets For Peripheral Vascular Stent Products 2014
M2 - Wed Dec 17, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/shjv4r/global_markets) has announced the addition of the "Global Markets For Peripheral Vascular Stent Products" report to their offering. This 2014 report provides a detailed assessment of the current and forecast market. The study also provides a detailed assessment of the competitive landscape including established companies and disruptive emerging companies. The analysis quantifies current and forecast patient populations, procedure volumes, and market size. Competitor sales, unit volumes, ASPs, and market shares are provided for each segment. Key Topics Covered: 1. EXECUTIVE SUMMARY 2. OVERVIEW 3. PERIPHERAL VASCULAR STENT PRODUCTS 4. PROCEDURE FORECASTS & MARKET ANALYSIS 5. COMPANY PROFILES - Abbott Vascular (Abbott) - Bard Peripheral Vascular (C.R. Bard) - Boston Scientific - Cook Medical (Cook Group) - Cordis Corporation (Johnson & Johnson) - Covidien - Medtronic - W.L. Gore and Associates For more information visit http://www.researchandmarkets.com/research/sh...al_markets
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31)
CR Bard (BCR) Faces Series of Lawuits - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 4:25PM CST
CR Bard Inc. (BCR) has been hit by a wave of product liability lawsuits over its faulty pelvic mesh products and defective vaginal-mesh implants, which could result in billions of dollars in damages.
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), ENDP: 72.10 (+0.34), BCR: 169.10 (-0.44)
Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 3:50PM CST
On Dec 16, 2014, Zacks Investment Research upgraded Boston Scientific Corporation (BSX) to a Zacks Rank #2 (Buy).
MGNX: 33.00 (+0.34), BSX: 13.13 (+0.07), ABAX: 58.48 (+0.22), HSP: 62.60 (-0.07)
Boston Scientific's Chronic Pain Cure Solution Tests Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 2:40PM CST
The study results are indicative of the fact that Boston Scientific's (BSX) next-generation Precision Spectra SCS System can offer sustainable respite for patients suffering from chronic low back pain.
BSX: 13.13 (+0.07), ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), OSUR: 10.26 (+0.25)
Market Influences That Drive Equities Forward: Research Report on Advaxis, Barnwell, MRV, Navidea and Boston Scientific
PR Newswire - Tue Dec 16, 7:44AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations. Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
BSX: 13.13 (+0.07)
Boston Scientific (BSX) Spotted As Roof Leaker Today
at The Street - Mon Dec 15, 12:49PM CST
Trade-Ideas LLC identified Boston Scientific (BSX) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
BSX: 13.13 (+0.07)
United States Medical Equipment and Supplies Manufacturing Industry Analytic 2014-2021: Industry to reach $142.9 billion by 2021
M2 - Mon Dec 15, 8:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/3ntjwz/medical_equipment) has announced the addition of Plunkett Research Ltd's new report "Medical Equipment and Supplies Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Medical Equipment and Supplies Manufacturing Industry (U.S.) to reach $142.9 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements - 3M Company - Baxter International Inc - Becton Dickinson & Co - Boston Scientific Corp - DePuy Synthes Inc - Ethicon Inc - St Jude Medical Inc - St Jude Medical Neuromodulation - Stryker Corp - Zimmer Holdings Inc For more information visit http://www.researchandmarkets.com/research/3n..._equipment Source: Plunkett Research Ltd
ZMH: 114.11 (+0.64), BSX: 13.13 (+0.07), MMM: 166.96 (+0.09), BDX: 139.90 (+1.44), BAX: 74.45 (-0.04), SYK: 96.00 (-0.61)